VJHemOnc is committed to improving our service to you

IMW 2019 | MGUS pathology

VJHemOnc is committed to improving our service to you

Tarek H Mouhieddine

Tarek H Mouhieddine, MD, Dana-Farber Cancer Institute, Boston, MA, outlines the pathology and prognosis of monoclonal gammopathy of undetermined significance (MGUS) at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter